drugset / Trial / NCT00651547

Symbicort in Asthmatic Children - SEEDLING

NCT00651547

Phase 3 Completed 405 enrolled AstraZeneca
RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to compare Symbicort with budesonide alone and formoterol alone in the treatment of asthma in children aged 6 to 11 years

Timeline

Start
2002-07
Primary completion
Completion
2003-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator Budesonide Small molecule
Comparator Formoterol Other / unclassified

Indications